Search results
3 Things You Need to Know If You Buy Novavax Today
The Motley Fool via AOL· 2 days agoNovavax (NASDAQ: NVAX) stock has both soared and plummeted at times in recent years. Investors initially bet on the biotech company to be a winner in the...
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Motley Fool via Yahoo Finance· 4 months agoNovavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability...
Novavax (NVAX) Q4 Earnings & Revenues Miss Estimates, Stock Down
Zacks via Yahoo Finance· 1 year agoNovavax (NVAX) reports worse-than-expected financial performance in the fourth quarter of 2022, with...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 7 days agoNovavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their...
Novavax Stock Just Tripled. Is It Too Late to Buy?
The Motley Fool via AOL· 1 week agoAfter losing more than 90% of its value from a peak back in 2021, Novavax (NASDAQ: NVAX) stock has finally taken off. The biotech soared 190% in two...
Will Novavax's Covid Booster Thesis Play Out? What The Survey Says
Investor's Business Daily· 2 years agoNovavax's Covid booster is preemptively gaining steam, according to the July IBD/TIPP Poll. The...
FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines
CBS News via Yahoo News· 2 years agoThe Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...
Could Novavax Stock Help You Become a Millionaire?
Motley Fool via Yahoo Finance· 4 months agoNovavax (NASDAQ: NVAX) stock may have made some millionaires back in 2020. It was the height of the coronavirus vaccine race, and investors were betting...
Has Novavax Just Solved Its Biggest Problem?
Motley Fool via Yahoo Finance· 3 months agoMany investors have seen Novavax (NASDAQ: NVAX) as a promising recovery story ever since the biotech launched a plan to cut costs to better match the...
IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine
Investor's Business Daily· 2 years agoNovavax could struggle to find a U.S. market for its Covid vaccine, according to the latest IBD/TIPP...